Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-23

Clinical Trial Update: Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial comparing oral insulin with subcutaneous regular human insulin in patients with Type 2 diabetes has completed. The study was sponsored by Profil I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral insulin (insulin)
  • Regular human insulin (human insulin (regular))

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED